Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$8.01 - $8.64 $45,632 - $49,222
-5,697 Reduced 20.03%
22,746 $187,000
Q1 2024

Apr 10, 2024

SELL
$8.02 - $8.67 $81,010 - $87,575
-10,101 Reduced 26.21%
28,443 $241,000
Q4 2023

Jan 11, 2024

SELL
$7.78 - $8.62 $22,507 - $24,937
-2,893 Reduced 6.98%
38,544 $317,000
Q3 2023

Oct 10, 2023

SELL
$7.85 - $8.94 $5,973 - $6,803
-761 Reduced 1.8%
41,437 $345,000
Q2 2023

Jul 10, 2023

SELL
$8.04 - $9.0 $14,238 - $15,939
-1,771 Reduced 4.03%
42,198 $353,000
Q1 2023

Apr 10, 2023

SELL
$7.57 - $8.37 $17,698 - $19,569
-2,338 Reduced 5.05%
43,969 $357,000
Q4 2022

Jan 10, 2023

BUY
$5.96 - $8.06 $275,989 - $373,234
46,307 New
46,307 $371,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Thomasville National Bank Portfolio

Follow Thomasville National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomasville National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Thomasville National Bank with notifications on news.